Clinical Outcomes of Behavioral Treatments for Pica in Children with Developmental Disabilities

Call, Nathan A.; Simmons, Christina; Mevers, Joanna Lomas; Alvarez, Jessica

doi:10.1007/s10803-015-2375-z

Cited by 44 publications

(37 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pica is reported in up to one-quarter of preschool-aged children with ASD and is documented to persist in individuals with intellectual disability. 416,417 The persistence of pica may be attributable to sensory differences, perseveration or obsession, and oral exploration of the environment. Clinicians need to be aware of persistence of pica in children and youth with ASD because of the risk for toxic ingestions, risk for lead intoxication, potential for infection, and the risk for mechanical ingestions ranging from batteries to bezoars.…”

Section: Picamentioning

confidence: 99%

Identification, Evaluation, and Management of Children With Autism Spectrum Disorder

2020

View full text Add to dashboard Cite

Autism spectrum disorder (ASD) is a common neurodevelopmental disorder with reported prevalence in the United States of 1 in 59 children (approximately 1.7%). Core deficits are identified in 2 domains: social communication/interaction and restrictive, repetitive patterns of behavior. Children and youth with ASD have service needs in behavioral, educational, health, leisure, family support, and other areas. Standardized screening for ASD at 18 and 24 months of age with ongoing developmental surveillance continues to be recommended in primary care (although it may be performed in other settings), because ASD is common, can be diagnosed as young as 18 months of age, and has evidenced-based interventions that may improve function. More accurate and culturally sensitive screening approaches are needed. Primary care providers should be familiar with the diagnostic criteria for ASD, appropriate etiologic evaluation, and co-occurring medical and behavioral conditions (such as disorders of sleep and feeding, gastrointestinal tract symptoms, obesity, seizures, attention-deficit/hyperactivity disorder, anxiety, and wandering) that affect the child' s function and quality of life. There is an increasing evidence base to support behavioral and other interventions to address specific skills and symptoms. Shared decision making calls for collaboration with families in evaluation and choice of interventions. This single clinical report updates the 2007 American Academy of Pediatrics clinical reports on the evaluation and treatment of ASD in one publication with an online table of contents and section view available through the American Academy of Pediatrics Gateway to help the reader identify topic areas within the report.

show abstract

Section: Picamentioning

confidence: 99%

Identification, Evaluation, and Management of Children With Autism Spectrum Disorder

2020

View full text Add to dashboard Cite

show abstract

“…These methods have also been used to examine the outcomes associated with treatment procedures including FCT (Greer et al, ; Hagopian et al, ; Rooker et al, ) and NCR (Phillips et al, ). In addition to evaluating the general efficacy of assessment and treatment procedures, these methods have been used to examine the generality of procedures to specific populations, including preschool children with severe behavior (Kurtz et al, ), individuals with fragile X syndrome (Kurtz et al, ), and for specific problem behaviors (e.g., pica; Call et al, ).…”

Section: The Consecutive Controlled Case Series (Cccs)mentioning

confidence: 99%

The consecutive controlled case series: Design, data‐analytics, and reporting methods supporting the study of generality

Hagopian

2020

J of App Behav Analysis

119

106

View full text Add to dashboard Cite

Single‐case experimental designs (SCEDs) have proven invaluable in research and practice because they are optimal for asking many experimental questions relevant to the analysis of behavior. The consecutive controlled case series (CCCS) is a type of study in which a SCED is employed in a series of consecutively encountered cases that undergo a common procedure or share a common characteristic. Additional design elements, data‐analytic, and reporting methods enable researchers to ask experimental questions relevant to the study of generality of procedures and processes. The current paper discusses the CCCS methodologies, including the retrospective, prospective, and randomized CCCS. These methodologies can be applied to examine the generality of clinical procedures (including their general efficacy, the limits of their generality, and variables that may mediate generality); study the epidemiology and phenomenology of clinical problems; and compare the efficacy of 2 clinical procedures within a randomized controlled trial combining SCEDs with randomized group designs.

show abstract

“…needing mom to get me a cookie), or 2) an automatic behavior which does not require anyone else to meet the goal (i.e. hitting self in the head because it feels good [22]. His group has also demonstrated significant improvement in encopresis by using a multidisciplinary approach after 4 weeks of intensive therapy in a small group of 20 patients [23].…”

Section: Session 2: Epilepsy Jimmy Holder MD Phd Baylor College Omentioning

confidence: 99%

Bringing everyone to the table – findings from the 2018 Phelan-McDermid Syndrome Foundation International Conference

Goodspeed

Bliss

Linnehan

2020

Orphanet J Rare Dis

View full text Add to dashboard Cite

Background: Phelan-McDermid Syndrome (PMS) is a rare neurodevelopmental disorder characterized by global developmental delay, autism spectrum disorder, and numerous systemic complications including seizures, gastrointestinal dysfunction, and renal anomalies. The Phelan-McDermid Syndrome Foundation (PMSF) was created to improve the quality of life of people affected by PMS worldwide by supporting families, accelerating research, and raising awareness. To further this mission, the PMSF initiated the Phelan-McPosium in 2016 to bring families affected by PMS, clinicians, and researchers together to design patient-centered rigorous clinical and translational research. Here, we present findings from the 2018 Phelan-McPosium. Results: The 2018 Phelan-McPosium was attended by 183 families and 35 researchers and clinicians. Overall, the Early Childhood parents raised the fewest number of concerns, families of Late-Childhood patients raised more concerns around epilepsy and behavioral problems, and Teen and Adult families were primarily concerned about implications of genetic testing, gastrointestinal dysfunction, and regression. All families were concerned with feasibility, safety and importance of clinical trials for PMS. Conclusions: The concerns raised by families across the sessions varied by age in a manner which may overlap with the emergence of various signs and symptoms through the natural history of PMS. The design of the Phelan-McPosium session has successfully generated thoughtful research questions that led to innovative investigations and clinical trials that are shaping the standard of care for PMS. This is an approach which could be employed by any rare disease group to align translational research efforts with a patient-centered focus.

show abstract

Clinical Outcomes of Behavioral Treatments for Pica in Children with Developmental Disabilities

Cited by 44 publications

References 24 publications

Identification, Evaluation, and Management of Children With Autism Spectrum Disorder

Identification, Evaluation, and Management of Children With Autism Spectrum Disorder

The consecutive controlled case series: Design, data‐analytics, and reporting methods supporting the study of generality

Bringing everyone to the table – findings from the 2018 Phelan-McDermid Syndrome Foundation International Conference

Contact Info

Product

Resources

About